Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

BACKGROUND: Resection of colorectal cancer liver metastasis (CRCLM) with curative intent has long-term benefit in ∼40% of cases. Prognostic biomarkers are needed to improve clinical management and reduce futile surgeries. Expression of epidermal growth factor receptor (EGFR) and prostaglandin-endope...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Goos, J A C M, Hiemstra, A C, Coupé, V M H, Diosdado, B, Kooijman, W, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Menke-van der Houven van Oordt, C W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4134500/
https://ncbi.nlm.nih.gov/pubmed/24983372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.354
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares